<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40916524</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1673-4254</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>Nan fang yi ke da xue xue bao = Journal of Southern Medical University</Title><ISOAbbreviation>Nan Fang Yi Ke Da Xue Xue Bao</ISOAbbreviation></Journal><ArticleTitle>[<i>Qihuang Jianpi Zishen</i> Granules ameliorate renal damage in MRL/lpr mice by inhibiting the MyD88/NF-&#x3ba;B pathway].</ArticleTitle><Pagination><StartPage>1625</StartPage><EndPage>1632</EndPage><MedlinePgn>1625-1632</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12122/j.issn.1673-4254.2025.08.07</ELocationID><ELocationID EIdType="pii" ValidYN="Y">1673-4254(2025)08-1625-08</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate the mechanism of <i>Qihuang Jianpi Zishen Granules</i> (QJZ) for ameliorating renal damage in MRL/lpr mice.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">With 6 female C57BL/6 mice as the normal control group, 30 female MRL/lpr mice were randomized into model group, QJZ treatment groups at low, moderate and high doses, and prednisone treatment group (<i>n=</i>6). After 8 weeks of treatment, the mice were examined for 24-h urine protein, creatinine and albumin levels, serum levels of IgG, complement 3 (C3), C4, anti-dsDNA, interferon &#x3b3; (IFN&#x2011;&#x3b3;) and interleukin 17 (IL-17). Kidney tissues were sampled for histopathological examination with HE staining and observation of glomerular ultrastructure changes using transmission electron microscopy (TEM). The expressions of MyD88/NF-&#x3ba;B pathway-related molecules in the kidney tissue were detected using RT-qPCR, Western blotting and immunohistochemistry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with those in the model group, the mice treated with QJZ at the 3 doses and prednisone showed significant reductions in the renal injury biomarkers and serum IgG, anti-dsDNA, IFN&#x2011;&#x3b3; and IL-17 levels and elevation of serum C3 and C4 levels. HE staining revealed lessened glomerular endothelial cell proliferation and mesangial thickening in all the treatment groups. TEM observation further demonstrated reduced electron-dense deposits and diminished inflammatory cell infiltration in the glomeruli in the intervention groups. QJZ at the 3 doses and prednisone treatment all significantly lowered renal expression levels of MyD88, NF-&#x3ba;B, p65 and p52 in the mouse models.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">QJZ can improve renal damage in MRL/lpr mice possibly by inhibiting overactivation of the MyD88/NF-&#x3ba;B pathway.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Zhongfu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Anhui University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chuanbing</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Anhui University of Chinese Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Hefei 230031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Anhui University of Chinese Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Hefei 230031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Anhui University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junjie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Anhui University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Shuangshuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Anhui University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sidi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>First Affiliated Hospital of Anhui University of Chinese Medicine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>82104782</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Nan Fang Yi Ke Da Xue Xue Bao</MedlineTA><NlmUniqueID>101266132</NlmUniqueID><ISSNLinking>1673-4254</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507780">Myd88 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004365" MajorTopicYN="Y">Drugs, Chinese Herbal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053594" MajorTopicYN="Y">Myeloid Differentiation Factor 88</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="Y">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="Y">Kidney</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020381" MajorTopicYN="N">Interleukin-17</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;</b>: &#x57fa;&#x4e8e;MyD88/NF-&#x3ba;B&#x901a;&#x8def;&#x63a2;&#x8ba8;&#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#xff08;QJZ&#xff09;&#x6539;&#x5584;MRL/lpr&#x5c0f;&#x9f20;&#x80be;&#x635f;&#x5bb3;&#x7684;&#x4f5c;&#x7528;&#x673a;&#x5236;&#x3002;<b>&#x65b9;&#x6cd5;</b>: 6&#x53ea;&#x96cc;&#x6027;C57BL/6&#x5c0f;&#x9f20;&#x4e3a;&#x6b63;&#x5e38;&#x5bf9;&#x7167;&#x7ec4;&#xff08;Control&#x7ec4;&#xff09;&#xff0c;&#x5c06;30&#x53ea;&#x96cc;&#x6027;MRL/lpr&#x5c0f;&#x9f20;&#x968f;&#x673a;&#x5206;&#x4e3a;&#x6a21;&#x578b;&#x7ec4;&#xff08;Model&#x7ec4;&#xff09;&#x3001;&#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x4f4e;&#x5242;&#x91cf;&#x7ec4;&#xff08;QJZ-L&#x7ec4;&#xff09;&#x3001;&#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x4e2d;&#x5242;&#x91cf;&#x7ec4;&#xff08;QJZ-M&#x7ec4;&#xff09;&#x3001;&#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x9ad8;&#x5242;&#x91cf;&#x7ec4;&#xff08;QJZ-H&#x7ec4;&#xff09;&#x3001;&#x6cfc;&#x5c3c;&#x677e;&#x7ec4;&#xff08;Pred&#x7ec4;&#xff09;&#xff0c;6&#x53ea;/&#x7ec4;&#x3002;&#x5e72;&#x9884;8&#x5468;&#x540e;&#x53d6;&#x5404;&#x7ec4;&#x5c0f;&#x9f20;&#x7684;&#x5c3f;&#x6db2;&#x3001;&#x5168;&#x8840;&#x53ca;&#x80be;&#x810f;&#x7ec4;&#x7ec7;&#xff0c;&#x751f;&#x5316;&#x8bd5;&#x5242;&#x76d2;&#x68c0;&#x6d4b;&#x80be;&#x635f;&#x5bb3;&#x6307;&#x6807;&#xff1a;24 h&#x5c3f;&#x86cb;&#x767d;&#x5b9a;&#x91cf;&#xff08;24 h PRO&#xff09;&#x3001;&#x5c3f;&#x603b;&#x86cb;&#x767d;&#x808c;&#x9150;&#x6bd4;&#x503c;&#xff08;UTPCR&#xff09;&#x3001;&#x5c3f;&#x86cb;&#x767d;&#x808c;&#x9150;&#x6bd4;&#xff08;UACR&#xff09;&#x3002;ELISA&#x6cd5;&#x68c0;&#x6d4b;&#x8840;&#x6e05;&#x4e2d;&#x514d;&#x75ab;&#x7403;&#x86cb;&#x767d;G&#xff08;IgG&#xff09;&#x3001;&#x8865;&#x4f53;3&#xff08;C3&#xff09;&#x3001;&#x8865;&#x4f53;4&#xff08;C4&#xff09;&#x3001;&#x6297;&#x53cc;&#x94fe;DNA&#x6297;&#x4f53;&#xff08;anti-dsDNA&#xff09;&#x3001;&#x5e72;&#x6270;&#x7d20;&#x3b3;&#xff08;IFN-&#x3b3;&#xff09;&#x3001;&#x767d;&#x7ec6;&#x80de;&#x4ecb;&#x7d20;17&#xff08;IL-17&#xff09;&#x3002;&#x80be;&#x810f;&#x7ec4;&#x7ec7;&#x8fdb;&#x884c;HE&#x67d3;&#x8272;&#x548c;&#x900f;&#x5c04;&#x7535;&#x955c;&#x89c2;&#x5bdf;&#x80be;&#x5c0f;&#x7403;&#x8d85;&#x5fae;&#x7ed3;&#x6784;&#x3002;&#x91c7;&#x7528;RT-qPCR&#x3001;Western blotting&#x548c;&#x514d;&#x75ab;&#x7ec4;&#x5316;&#x6cd5;&#x68c0;&#x6d4b;&#x80be;&#x7ec4;&#x7ec7;&#x4e2d;MyD88/NF-&#x3ba;B&#x901a;&#x8def;&#x76f8;&#x5173;&#x5206;&#x5b50;&#x7684;&#x8868;&#x8fbe;&#x3002;<b>&#x7ed3;&#x679c;</b>: &#x4e0e;Model&#x7ec4;&#x76f8;&#x6bd4;&#xff0c;QJZ-L&#x3001;QJZ-M&#x3001;QJZ-H&#x548c;Pred&#x7ec4;24 h PRO&#x3001;UTPCR&#x3001;UACR&#x3001;IgG&#x3001;anti-dsDNA&#x3001;IFN-&#x3b3;&#x3001;IL-17&#x964d;&#x4f4e;&#xff08;<i>P</i>&lt;0.01&#xff09;&#xff0c;C3&#x3001;C4&#x6c34;&#x5e73;&#x5347;&#x9ad8;&#xff08;<i>P</i>&lt;0.01&#xff09;&#x3002;HE&#x67d3;&#x8272;&#x7ed3;&#x679c;&#x663e;&#x793a;&#xff0c;&#x4e0e;Model&#x7ec4;&#x6bd4;&#x8f83;&#xff0c;&#x5404;&#x7ec4;&#x80be;&#x5c0f;&#x7403;&#x5185;&#x76ae;&#x7ec6;&#x80de;&#x589e;&#x751f;&#x3001;&#x7cfb;&#x819c;&#x589e;&#x539a;&#x51cf;&#x8f7b;&#x3002;&#x900f;&#x5c04;&#x7535;&#x955c;&#x663e;&#x793a;&#xff0c;&#x5404;&#x7ec4;&#x80be;&#x5c0f;&#x7403;&#x7535;&#x5b50;&#x81f4;&#x5bc6;&#x7269;&#x6c89;&#x79ef;&#x3001;&#x708e;&#x6027;&#x7ec6;&#x80de;&#x6d78;&#x6da6;&#x8f83;Model&#x7ec4;&#x51cf;&#x8f7b;&#x3002;RT-qPCR&#x548c;&#x514d;&#x75ab;&#x7ec4;&#x5316;&#x7ed3;&#x679c;&#x663e;&#x793a;&#xff0c;&#x4e0e;Model&#x7ec4;&#x76f8;&#x6bd4;&#xff0c;QJZ-L&#x3001;QJZ-M&#x3001;QJZ-H&#x548c;Pred&#x7ec4;&#x80be;&#x810f;&#x4e2d;MyD88&#x3001;NF-&#x3ba;B&#x8868;&#x8fbe;&#x4e0b;&#x964d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#x3002;Western blotting&#x7ed3;&#x679c;&#x663e;&#x793a;&#xff0c;&#x5404;&#x7ec4;&#x80be;&#x810f;&#x4e2d;p65&#x3001;p52&#x86cb;&#x767d;&#x6c34;&#x5e73;&#x4f4e;&#x4e8e;Model&#x7ec4;&#xff08;<i>P</i>&lt;0.01&#xff09;&#x3002;<b>&#x7ed3;&#x8bba;</b>: &#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x80fd;&#x591f;&#x6539;&#x5584;MRL/lpr&#x5c0f;&#x9f20;&#x80be;&#x635f;&#x5bb3;&#xff0c;&#x5176;&#x673a;&#x5236;&#x53ef;&#x80fd;&#x4e0e;&#x6291;&#x5236;MyD88/NF-&#x3ba;B&#x901a;&#x8def;&#x8fc7;&#x5ea6;&#x6fc0;&#x6d3b;&#x6709;&#x5173;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MRL/lpr mice</Keyword><Keyword MajorTopicYN="N">MyD88/NF&#x2011;&#x3ba;B pathway</Keyword><Keyword MajorTopicYN="N">Qihuang Jianpi Zishen Granules</Keyword><Keyword MajorTopicYN="N">renal damage</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no competinginterests.&#x3002;</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40916524</ArticleId><ArticleId IdType="pmc">PMC12415576</ArticleId><ArticleId IdType="doi">10.12122/j.issn.1673-4254.2025.08.07</ArticleId><ArticleId IdType="pii">1673-4254(2025)08-1625-08</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhao G, Li X, Zhang Y, et al. Intricating connections: the role of ferroptosis in systemic lupus erythematosus[J]. Front Immunol, 2025, 16: 1534926. doi&#xff1a; 10.3389/fimmu.2025.1534926</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2025.1534926</ArticleId><ArticleId IdType="pmc">PMC11832682</ArticleId><ArticleId IdType="pubmed">39967676</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfon M, Tankeu AT, Ribi C. Mitochondrial dysfunction in systemic lupus erythematosus with a focus on lupus nephritis[J]. Int J Mol Sci, 2024, 25(11): 6162. doi&#xff1a; 10.3390/ijms25116162</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25116162</ArticleId><ArticleId IdType="pmc">PMC11173067</ArticleId><ArticleId IdType="pubmed">38892349</ArticleId></ArticleIdList></Reference><Reference><Citation>Accapezzato D, Caccavale R, Paroli MP, et al. Advances in the pathogenesis and treatment of systemic lupus erythematosus[J]. Int J Mol Sci, 2023, 24(7): 6578. doi&#xff1a; 10.3390/ijms24076578</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076578</ArticleId><ArticleId IdType="pmc">PMC10095030</ArticleId><ArticleId IdType="pubmed">37047548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi D, Silvagni E, Elefante E, et al. Systemic lupus erythematosus: one year in review 2023[J]. Clin Exp Rheumatol, 2023, 41(5): 997-1008.</Citation><ArticleIdList><ArticleId IdType="pubmed">37133502</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets[J]. Ann Rheum Dis, 2023, 82(8): 999-1014. doi&#xff1a; 10.1136/ard-2022-223741</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-223741</ArticleId><ArticleId IdType="pubmed">36792346</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x9648;&#x5c11;&#x654f;, &#x674e;&#x7ea2;&#x6bc5;, &#x5218; &#x70bd;, &#x7b49;. &#x57fa;&#x4e8e;CiteSpace&#x7684;&#x4e2d;&#x533b;&#x836f;&#x6cbb;&#x7597;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x53ef;&#x89c6;&#x5316;&#x5206;&#x6790;[J]. &#x65b0;&#x4e2d;&#x533b;, 2024, 56(24): 184-91. doi&#xff1a; 10.13457/j.cnki.jncm.2024.24.037</Citation><ArticleIdList><ArticleId IdType="doi">10.13457/j.cnki.jncm.2024.24.037</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x6731;&#x96c5;&#x6587;, &#x9ec4;&#x4f20;&#x5175;, &#x674e; &#x660e;, &#x7b49;. &#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x6cbb;&#x7597;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x60a3;&#x8005;&#x7597;&#x6548;&#x89c2;&#x5bdf;&#x53ca;&#x5bf9;&#x5916;&#x5468;&#x8840;Toll&#x6837;&#x53d7;&#x4f53;&#x8868;&#x8fbe;&#x6c34;&#x5e73;&#x7684;&#x5f71;&#x54cd;[J]. &#x4e2d;&#x533b;&#x836f;&#x5b66;&#x62a5;, 2025, 53(2): 67-71.</Citation></Reference><Reference><Citation>&#x94b1; &#x7231;, &#x7a0b;&#x56ed;&#x56ed;, &#x6731;&#x96c5;&#x6587;, &#x7b49;. &#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x6cbb;&#x7597;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x7684;&#x7597;&#x6548;&#x89c2;&#x5bdf;[J]. &#x5b89;&#x5fbd;&#x4e2d;&#x533b;&#x836f;&#x5927;&#x5b66;&#x5b66;&#x62a5;, 2023, 42(6): 7-12. doi&#xff1a; 10.3969/j.issn.2095-7246.2023.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.2095-7246.2023.06.003</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x674e; &#x660e;, &#x5c1a;&#x53cc;&#x53cc;, &#x674e;&#x4e91;&#x98de;, &#x7b49;. &#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x6cbb;&#x7597;&#x813e;&#x80be;&#x4e8f;&#x865a;&#x578b;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x7684;&#x4e34;&#x5e8a;&#x7597;&#x6548;&#x89c2;&#x5bdf;[J]. &#x65f6;&#x73cd;&#x56fd;&#x533b;&#x56fd;&#x836f;, 2023, 34(2): 370-3. doi&#xff1a; 10.3969/j.issn.1008-0805.2023.02.31</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1008-0805.2023.02.31</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x9648;&#x541b;&#x6d01;, &#x9ec4;&#x4f20;&#x5175;, &#x7a0b;&#x4e3d;&#x4e3d;, &#x7b49;. &#x82aa;&#x9ec4;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x9897;&#x7c92;&#x8c03;&#x63a7;JAK1/STAT1&#x4fe1;&#x53f7;&#x901a;&#x8def;&#x5bf9;MRL/lpr&#x72fc;&#x75ae;&#x5c0f;&#x9f20;&#x8db3;&#x7ec6;&#x80de;&#x51cb;&#x4ea1;&#x7684;&#x5f71;&#x54cd;[J]. &#x4e2d;&#x6210;&#x836f;, 2024, 46(12): 4145-50.</Citation></Reference><Reference><Citation>Baek WY, Choi YS, Lee SW, et al. Toll-like receptor signaling inhibitory peptide improves inflammation in animal model and human systemic lupus erythematosus[J]. Int J Mol Sci, 2021, 22(23): 12764. doi&#xff1a; 10.3390/ijms222312764</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222312764</ArticleId><ArticleId IdType="pmc">PMC8657918</ArticleId><ArticleId IdType="pubmed">34884569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao B, Xiang W, Li XL, et al. Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus[J]. Inflamm Res, 2021, 70(3): 285-96. doi&#xff1a; 10.1007/s00011-020-01433-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01433-y</ArticleId><ArticleId IdType="pubmed">33507312</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Ji S, Liu L, et al. Promotion of TLR7-MyD88-dependent inflammation and autoimmunity in mice through stem-loop changes in Lnc-Atg16l1[J]. Nat Commun, 2024, 15(1): 10224. doi&#xff1a; 10.1038/s41467-024-54674-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-54674-4</ArticleId><ArticleId IdType="pmc">PMC11589596</ArticleId><ArticleId IdType="pubmed">39587108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilstra JS, Kim M, Gordon RA, et al. B cell-intrinsic Myd88 regulates disease progression in murine lupus[J]. J Exp Med, 2023, 220(12): e20230263. doi&#xff1a; 10.1084/jem.20230263</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20230263</ArticleId><ArticleId IdType="pmc">PMC10541815</ArticleId><ArticleId IdType="pubmed">37787782</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x5415;&#x51ac;&#x83ca;, &#x9ec4;&#x4e1c;&#x660e;, &#x6bb5;&#x4f1f;&#x9759;. &#x9ec4;&#x82aa;&#x7532;&#x82f7;&#x8c03;&#x63a7;HMGB1/NF-&#x3ba;B&#x901a;&#x8def;&#x5bf9;&#x8113;&#x6bd2;&#x75c7;&#x5927;&#x9f20;&#x5de8;&#x566c;&#x7ec6;&#x80de;&#x6781;&#x5316;&#x548c;&#x6025;&#x6027;&#x80be;&#x635f;&#x4f24;&#x7684;&#x673a;&#x5236;&#x7814;&#x7a76;[J]. &#x4e2d;&#x56fd;&#x7164;&#x70ad;&#x5de5;&#x4e1a;&#x533b;&#x5b66;&#x6742;&#x5fd7;, 2025, 28(1): 1-7.</Citation></Reference><Reference><Citation>Reynolds JA, Li Y, Herlitz L, et al. Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum[J]. J Autoimmun, 2024, 142: 103134. doi&#xff1a; 10.1016/j.jaut.2023.103134</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2023.103134</ArticleId><ArticleId IdType="pmc">PMC10957328</ArticleId><ArticleId IdType="pubmed">37944214</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chalmers SA, Ayilam Ramachandran R, Garcia SJ, et al. 
The CD6/ALCAM pathway promotes lupus nephritis <i>via</i> T cell-mediated responses[J]. J Clin Invest, 2022, 132(1): e147334. doi&#xff1a;
10.1172/jci147334

</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci147334</ArticleId><ArticleId IdType="pmc">PMC8718154</ArticleId><ArticleId IdType="pubmed">34981775</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai SB, Ahdoot R, Malik F, et al. New guidelines and therapeutic updates for the management of lupus nephritis[J]. Curr Opin Nephrol Hypertens, 2024, 33(3): 344-53. doi&#xff1a; 10.1097/mnh.0000000000000969</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mnh.0000000000000969</ArticleId><ArticleId IdType="pubmed">38334499</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x5c1a;&#x53cc;&#x53cc;, &#x674e; &#x660e;, &#x9ec4;&#x4f20;&#x5175;. &#x5065;&#x813e;&#x6ecb;&#x80be;&#x6cd5;&#x6cbb;&#x7597;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x7684;&#x7406;&#x8bba;&#x63a2;&#x6e90;[J]. &#x4e2d;&#x56fd;&#x4e2d;&#x533b;&#x57fa;&#x7840;&#x533b;&#x5b66;&#x6742;&#x5fd7;, 2023, 29(04): 663-5.</Citation></Reference><Reference><Citation>&#x94b1; &#x7231;, &#x9ec4;&#x4f20;&#x5175;, &#x6731;&#x96c5;&#x6587;, &#x7b49;. &#x57fa;&#x4e8e;&#x201c;&#x80be;-&#x813e;-&#x80a0;&#x8f74;&#x201d; &#x63a2;&#x8ba8;&#x5065;&#x813e;&#x6ecb;&#x80be;&#x6cd5;&#x8c03;&#x8282;&#x80a0;&#x9053;&#x83cc;&#x7fa4;&#x6cbb;&#x7597;&#x7cfb;&#x7edf;&#x6027;&#x7ea2;&#x6591;&#x72fc;&#x75ae;&#x7684;&#x53ef;&#x884c;&#x6027;[J]. &#x4e0a;&#x6d77;&#x4e2d;&#x533b;&#x836f;&#x6742;&#x5fd7;, 2024, 58(12): 52-5, 70.</Citation></Reference><Reference><Citation>
Tian HY, An LZ, Wang PW, et al. 
Review of <i>Astragalus membranaceus</i> polysaccharides: extraction process, structural features, bioactivities and applications[J]. Chin Herb Med, 2025, 17(1): 56-69. doi&#xff1a;
10.1016/j.chmed.2024.09.004

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chmed.2024.09.004</ArticleId><ArticleId IdType="pmc">PMC11814244</ArticleId><ArticleId IdType="pubmed">39949812</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x5f20; &#x6167;, &#x7f57;&#x8fdb;&#x8f89;, &#x6768; &#x67f3;, &#x7b49;. &#x9ec4;&#x82aa;&#x591a;&#x7cd6;&#x8c03;&#x8282;TGF-&#x3b2;1/Smad/AP-1&#x4fe1;&#x53f7;&#x901a;&#x8def;&#x5bf9;&#x6162;&#x6027;&#x80be;&#x8870;&#x7aed;&#x5927;&#x9f20;&#x80be;&#x7ea4;&#x7ef4;&#x5316;&#x7684;&#x5f71;&#x54cd;[J]. &#x4e2d;&#x56fd;&#x8001;&#x5e74;&#x5b66;&#x6742;&#x5fd7;, 2024, 44(16): 4040-4.</Citation></Reference><Reference><Citation>&#x9648;&#x9c81;&#x5b81;, &#x80e1; &#x626c;, &#x8f9b;&#x56fd;&#x677e;, &#x7b49;. &#x83df;&#x4e1d;&#x5b50;&#x5316;&#x5b66;&#x6210;&#x5206;&#x3001;&#x836f;&#x7406;&#x4f5c;&#x7528;&#x7814;&#x7a76;&#x8fdb;&#x5c55;&#x53ca;&#x5176;&#x8d28;&#x91cf;&#x6807;&#x5fd7;&#x7269;(Q-Marker)&#x9884;&#x6d4b;[J]. &#x4e2d;&#x8349;&#x836f;, 2024, 55(15): 5298-314. doi&#xff1a; 10.7501/j.issn.0253-2670.2024.15.029</Citation><ArticleIdList><ArticleId IdType="doi">10.7501/j.issn.0253-2670.2024.15.029</ArticleId></ArticleIdList></Reference><Reference><Citation>
Liu ZH, Xu QY, Wang Y, et al. 
Catalpol from <i>Rehmannia glutinosa</i> targets Nrf2/NF&#x2011;&#x3ba;B signaling pathway to improve renal <i>Anemia</i> and fibrosis[J]. Am J Chin Med, 2024, 52(5): 1451-85. doi&#xff1a;
10.1142/s0192415x24500575

</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/s0192415x24500575</ArticleId><ArticleId IdType="pubmed">39075978</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bailly C. Atractylenolides, essential components of <i>Atractylodes</i>-based traditional herbal medicines: Antioxidant, anti-inflammatory and anticancer properties[J]. Eur J Pharmacol, 2021, 891: 173735. doi&#xff1a;
10.1016/j.ejphar.2020.173735

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173735</ArticleId><ArticleId IdType="pubmed">33220271</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ding X, Li S, Huang H, et al. 
Bioactive triterpenoid compounds of <i>Poria cocos</i> (Schw.) Wolf in the treatment of diabetic ulcers <i>via</i> regulating the PI3K-AKT signaling pathway[J]. J Ethnopharmacol, 2024, 325: 117812. doi&#xff1a;
10.1016/j.jep.2024.117812

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2024.117812</ArticleId><ArticleId IdType="pubmed">38301984</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x65bd;&#x6c5f;&#x5357;, &#x6e29;&#x4e50;&#x4e50;, &#x6c5f;&#x4e3d;&#x6d01;, &#x7b49;. &#x57fa;&#x4e8e;&#x6587;&#x732e;&#x8ba1;&#x91cf;&#x5b66;&#x7684;&#x8986;&#x76c6;&#x5b50;&#x7814;&#x7a76;&#x70ed;&#x70b9;&#x4e0e;&#x8d8b;&#x52bf;&#x5206;&#x6790;[J]. &#x4e2d;&#x8349;&#x836f;, 2025, 56(2): 598-616. doi&#xff1a; 10.7501/j.issn.0253-2670.2025.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.7501/j.issn.0253-2670.2025.02.022</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x738b; &#x5e73;, &#x5b59;&#x6587;&#x5a1f;, &#x6f58;&#x4fdd;&#x671d;, &#x7b49;. &#x57fa;&#x4e8e;NLRP3&#x901a;&#x8def;&#x7814;&#x7a76;&#x91d1;&#x6a31;&#x5b50;&#x6291;&#x5236;&#x80be;&#x5c0f;&#x7ba1;&#x4e0a;&#x76ae;&#x7ec6;&#x80de;&#x95f4;&#x8d28;&#x5316;&#x6cbb;&#x7597;&#x7cd6;&#x5c3f;&#x75c5;&#x80be;&#x75c5;&#x7684;&#x4f5c;&#x7528;&#x673a;&#x5236;[J]. &#x5929;&#x6d25;&#x4e2d;&#x533b;&#x836f;, 2024, 41(11): 1468-74.</Citation></Reference><Reference><Citation>Chen Y, Tian B. IFN-&#x3b3; promotes the development of systemic lupus erythematosus through the IFNGR1/2-PSTAT1-TBX21 signaling axis[J]. Am J Transl Res, 2022, 14(10): 6874-88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9641460</ArticleId><ArticleId IdType="pubmed">36398225</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter P, Macovei LA, Mihai IR, et al. Cytokines in systemic lupus erythematosus-focus on TNF-&#x3b1; and IL-17[J]. Int J Mol Sci, 2023, 24(19): 14413. doi&#xff1a; 10.3390/ijms241914413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241914413</ArticleId><ArticleId IdType="pmc">PMC10572174</ArticleId><ArticleId IdType="pubmed">37833861</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer AL, Alcaide P. MyD88: At the heart of inflammatory signaling and cardiovascular disease[J]. J Mol Cell Cardiol, 2021, 161: 75-85. doi&#xff1a; 10.1016/j.yjmcc.2021.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2021.08.001</ArticleId><ArticleId IdType="pmc">PMC8629847</ArticleId><ArticleId IdType="pubmed">34371036</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen AM, Luan L, Burelbach KR, et al. MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages[J]. Front Immunol, 2022, 13: 1044662. doi&#xff1a; 10.3389/fimmu.2022.1044662</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1044662</ArticleId><ArticleId IdType="pmc">PMC9692127</ArticleId><ArticleId IdType="pubmed">36439136</ArticleId></ArticleIdList></Reference><Reference><Citation>
Yu T, Xiaojuan F, Jinxi L, et al. 
Extracellular HMGB1 induced glomerular endothelial cell injury <i>via</i> TLR4/MyD88 signaling pathway in lupus nephritis[J]. Mediators Inflamm, 2021, 2021: 9993971. doi&#xff1a;
10.1155/2021/9993971

</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9993971</ArticleId><ArticleId IdType="pmc">PMC8714399</ArticleId><ArticleId IdType="pubmed">34970076</ArticleId></ArticleIdList></Reference><Reference><Citation>
Feng X, Yang R, Tian Y, et al. 
HMGB1 protein promotes glomerular mesangial matrix deposition <i>via</i> TLR2 in lupus nephritis[J]. J Cell Physiol, 2020, 235(6): 5111-9. doi&#xff1a;
10.1002/jcp.29379

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.29379</ArticleId><ArticleId IdType="pubmed">31667864</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;velmeyer N, Schmidt-Supprian M, Ohnmacht C. NF&#x2011;&#x3ba;B in control of regulatory T cell development, identity, and function[J]. J Mol Med, 2022, 100(7): 985-95. doi&#xff1a; 10.1007/s00109-022-02215-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-022-02215-1</ArticleId><ArticleId IdType="pmc">PMC9213371</ArticleId><ArticleId IdType="pubmed">35672519</ArticleId></ArticleIdList></Reference><Reference><Citation>Caster DJ, Powell DW. Precision targeting of NF-&#x3ba;B signaling in lupus nephritis[J]. Lupus: Los Angel, 2020, 6(1): 160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9245607</ArticleId><ArticleId IdType="pubmed">35784620</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JS, Chen PH, Song YJ, et al. STING upregulation mediates ferroptosis and inflammatory response in lupus nephritis by upregulating TBK1 and activating NF&#x2011;&#x3ba;B signal pathway[J]. J Biosci, 2024, 49(1): 9. doi&#xff1a; 10.1007/s12038-023-00381-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12038-023-00381-z</ArticleId><ArticleId IdType="pubmed">38186000</ArticleId></ArticleIdList></Reference><Reference><Citation>
He LY, Niu SQ, Yang CX, et al. 

<i>Cordyceps</i> proteins alleviate lupus nephritis through modulation of the STAT3/mTOR/NF-&#x43a;B signaling pathway[J]. J Ethnopharmacol, 2023, 309: 116284. doi&#xff1a;
10.1016/j.jep.2023.116284
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2023.116284</ArticleId><ArticleId IdType="pubmed">36828195</ArticleId></ArticleIdList></Reference><Reference><Citation>
Su B, Ye H, You X, et al. 
Icariin alleviates murine lupus nephritis <i>via</i> inhibiting NF-&#x3ba;B activation pathway and NLRP3 inflammasome[J]. Life Sci, 2018, 208: 26-32. doi&#xff1a;
10.1016/j.lfs.2018.07.009

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.07.009</ArticleId><ArticleId IdType="pubmed">30146016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>